Clinical Trial Update: Effects of Insulin Detemir and NPH Insulin on Renal Handling of Sodium, Fluid Retention, and Weight in Type 2 Diabetic Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial reports on the effects of insulin detemir and NPH insulin on renal handling of sodium, fluid retention, and body weight in patients with Type 2 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin detemir (insulin detemir)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Diabetes Type 2, Weight Gain | Phase 4 | Status: COMPLETED